DuPont, the renowned materials manufacturer, has officially announced the sale of an 80.1% ownership interest in Delrin, an acetal homopolymer business. The buyer is the private-equity firm TJC LP. The deal, estimated at a value of $1.8 billion, is anticipated to conclude by the end of 2023, as stated in a press release.
Upon the completion of the transaction, DuPont is set to receive approximately $1.25 billion in pretax cash proceeds, subject to customary transaction adjustments. Additionally, they will hold a note receivable of $350 million. However, DuPont will retain a noncontrolling equity stake of 19.9% in the Delrin business.
CEO Ed Breen emphasized that this transaction aims to optimize value for shareholders, offering substantial cash proceeds to be utilized according to the company's strategic priorities. Furthermore, by retaining a stake in Delrin, DuPont also has the potential to benefit from future growth opportunities.
In response to this news, shares of DuPont (ticker: DD) experienced a 1.4% increase in premarket trading. So far this year, the company's stock has seen a solid climb of 9.9%.
Ai Holdings Expects 13% Increase in Operating Profit
Our Latest News
Crypto Traders in Short Supply, Affecting Coinbase's Q3 Report
Mizuho analysts revise down Coinbase's Q3 revenue estimates due to lower trading volumes. Regulatory crackdown and decline in retail interest pose challenges fo...
The Future of Crude Prices: A Shock to the System
Doug Lawler, CEO of Continental Resources, warns of high crude oil prices and the need for increased production to counterbalance price pressure.
Eupraxia Pharmaceuticals Advances Trial in Eosinophilic Esophagitis
Eupraxia Pharmaceuticals is advancing its trial for the treatment of eosinophilic esophagitis, with updates on dose escalation and enhanced assessments. The Pha...